Company / PP&E per Share
ClearPoint Neuro, Inc. PP&E per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.09
FY2025
5-year range
$0.03 / $0.09
FY2021-FY2025
Trend
+16.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
PP&E per Share has increased for 5 consecutive years, from $0.02 in FY2020 to $0.09 in FY2025.
Based on SEC 10-K filings.
0.09 in FY2025 with a 5-year CAGR of +35.3%.
Improved from $0.06 to $0.09 over the past 2 years.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- +40.7%
- 5-Year CAGR
- +35.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- ClearPoint Neuro, Inc.'s pp&e per share has grown for 5 consecutive years.
- In FY2025, pp&e per share increased 16.7% year-over-year.
- Peak pp&e per share was recorded in FY2016.
- Lowest pp&e per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -1.71 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.09 | +16.7% |
| FY2024 | $0.08 | +43.9% |
| FY2023 | $0.06 | +65.9% |
| FY2022 | $0.03 | +7.7% |
| FY2021 | $0.03 | +51.0% |
| FY2020 | $0.02 | -48.4% |
| FY2019 | $0.04 | +14.9% |
| FY2018 | $0.04 | -52.2% |
| FY2017 | $0.07 | -48.6% |
| FY2016 | $0.14 | +2340.6% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026